| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702713 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
Expression of galectin-9 is an independent prognostic factor for RFS and CSS in patients with UCB. Evaluation of galectin-9 expression may predict the benefit from adjuvant chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yidong M.D., Zheng M.D., Qiang M.D., Zewei M.D., Hangcheng M.D., Weisi M.D., Yiwei M.D., Jiejie M.D., Ph.D.,